Analysis of CD4+ T-Cell Responses to a Novel α-Fetoprotein-Derived Epitope in Hepatocellular Carcinoma Patients

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  2005-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-05-0382PMID 16166448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nomenclature for factors of the HLA system.

  2011cited by this paper
• α-Fetoprotein Impairs APC Function and Induces Their Apoptosis1

  2004cited by this paper
• Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.

  2004cited by this paper
• Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment.

  2003cited by this paper
• Cirrhotic Patients With or Without Hepatocellular Carcinoma Harbour AFP-Specific T-Lymphocytes That Can Be Activated in vitro by Human Alpha-Fetoprotein

  2002cited by this paper
• Immunotherapy of hepatocellular carcinoma

  2002cited by this paper
• T Cell Responses to HLA-A*0201-Restricted Peptides Derived from Human a Fetoprotein

  2001cited by this paper
• T Cell Responses to HLA-A*0201-Restricted Peptides Derived from Human α Fetoprotein1

  2001cited by this paper
• T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.

  2001cited by this paper
• Immunotherapy in hepatocellular carcinoma.

  2000cited by this paper
• Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice.

  2000cited by this paper
• Hepatocellular carcinoma

  1999cited by this paper
• Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.

  1999cited by this paper
• A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.

  1999cited by this paper
• Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

  1999cited by this paper
• A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors.

  1999cited by this paper
• Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

  1999cited by this paper
• α-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma

  1999cited by this paper
• Immunohistochemical demonstration of α-fetoprotein in small hepatocellular carcinoma

  1998cited by this paper
• Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.

  1998cited by this paper
• Nomenclature for Factors of the HLA System, 1996

  1997cited by this paper
• Nomenclature for factors of the HLA system, 1996.

  1997cited by this paper
• CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma.

  1997cited by this paper
• Nomenclature for factors of the HLA system, 1996.

  1997cited by this paper
• Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).

  1995cited by this paper
• Levels of peripheral T cell tolerance induced by different doses of tolerogen.

  1994cited by this paper
• T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?

  1994cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• The prevention of chemical hepatocarcinogenesis in rats by combining active and passive immunization with alpha-fetoprotein.

  1985cited by this paper
• Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients

  1985cited by this paper
• Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. II. Alpha-fetoprotein-induced suppression of cytotoxic T lymphocyte development

  1978cited by this paper
• alpha-Fetoprotein induces suppressor T cells in vitro.

  1977cited by this paper
• α-Fetoprotein induces suppressor T cells in vitro

  1977cited by this paper
• Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response

  1975cited by this paper

• Exploring the Multifunctional Role of Alpha-Fetoprotein in Cancer Progression: Implications for Targeted Therapy in Hepatocellular Carcinoma and Beyond

  2025cites this paper
• Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future

  2024cites this paper
• Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy.

  2023cites this paper
• Prognostic model of immune-related genes for patients with hepatocellular carcinoma

  2022cites this paper
• Immunomodulatory impact of α-fetoprotein.

  2022cites this paper
• Differential Virus-Specific IFN-Gamma Producing T Cell Responses to Marek’s Disease Virus in Chickens With B19 and B21 MHC Haplotypes

  2022cites this paper
• Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms

  2022cites this paper
• T‐cell mediated responses against alpha‐foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival

  2021cites this paper
• How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma

  2021cites this paper
• The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study.

  2020cites this paper
• A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma

  2020cites this paper
• Hepatobiliary Tumors: Immunopathology and Immunotherapy

  2020cites this paper
• From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma

  2019cites this paper
• Immune checkpoint inhibitors in gastrointestinal malignancies.

  2018cites this paper
• Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations

  2018cites this paper
• The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.

  2016cites this paper
• Adaptive immunity in the liver

  2016cites this paper
• Immunotherapy with immunomodulatory antibody for hepatocellular carcinoma

  2016cites this paper
• Potentiality of immunotherapy against hepatocellular carcinoma.

  2015cites this paper
• Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression

  2015cites this paper
• Changes in CD 4 and CD 8 after Interventional Management of Hepatocellular Carcinoma

  2015cites this paper
• Safety of Lienal Polypeptide Injection Combined with Chemotherapy in Treating Patients with Advanced Cancer.

  2015cites this paper
• Original Article Immunotherapy with immunomodulatory antibody for hepatocellular carcinoma

  2015cites this paper
• Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.

  2015cites this paper
• Antitumor CD8+T cells in hepatocellular carcinoma: Present but exhausted

  2014cites this paper
• Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies.

  2014cites this paper
• Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions

  2014cites this paper
• Alpha-fetoprotein: a renaissance

  2013cites this paper
• Alpha-fetoprotein and immunotherapy for hepatocellular carcinoma

  2012cites this paper
• Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

  2012cites this paper
• Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity

  2012cites this paper
• Cellular Immune Responses to Hepatocellular Carcinoma: Lessons for Immunotherapy

  2012cites this paper
• Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine.

  2011cites this paper
• Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model

  2011cites this paper
• Lack of ex vivo peripheral and intrahepatic α‐fetoprotein‐specific CD4+ responses in hepatocellular carcinoma

  2011cites this paper
• Immunoregulatory effects of AFP domains on monocyte-derived dendritic cell function

  2011cites this paper
• Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients.

  2011cites this paper
• Immunotherapy of hepatocellular carcinoma

  2010cites this paper
• Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.

  2010cites this paper
• Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC

  2010cites this paper
• Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

  2010cites this paper
• Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.

  2010cites this paper
• Cell‐mediated immune responses to α‐fetoprotein and other antigens in hepatocellular carcinoma

  2010cites this paper
• Models of Hepatocellular Carcinoma and Biomarker Strategy

  2010cites this paper
• Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.

  2008cites this paper
• Human CD4+ T Cells Recognize an Epitope within α-Fetoprotein Sequence and Develop into TGF-β-Producing CD4+ T Cells1

  2008cites this paper
• α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer

  2008cites this paper
• Unmasking of α-Fetoprotein-Specific CD4+ T Cell Responses in Hepatocellular Carcinoma Patients Undergoing Embolization1

  2007cites this paper
• Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer

  2007cites this paper
• AFP-specific CD4+ Helper T-cell Responses in Healthy Donors and HCC Patients

  2007cites this paper
• Tumor immunology: Hepatocellular carcinoma, cholangiocarcinoma, and metastatic neoplasms

  2007cites this paper
• Recent advances in immunotherapy for hepatocellular cancer.

  2006cites this paper
• Immunotherapy of hepatocellular carcinoma.

  2006cites this paper
• Current World Literature

  2006cites this paper
• Cancer Management and Research Dovepress

  year unknowncites this paper